Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel ACAT inhibitor from Nihon Nohyaku for hyperlipidemia and atherosclerosis

July 3, 1998

Benzamide derivatives in development at Kyorin for diabetes

July 3, 1998

ACAT inhibitors claimed by Sanwa for hyperlipidemia/atherosclerosis

July 3, 1998

Oxandrolone treatment results in robust anabolic effect in HIV-infected patients

July 3, 1998

New oxytocin antagonist for both parenteral and oral administration developed at Merck & Co.

July 2, 1998

JT develops more potent JTT-501 derivatives

July 2, 1998

Kissei investigates compounds for preventing abortion, premature birth

July 2, 1998

AMBI reports results confirming chromium picolinate's role in fat loss

July 2, 1998

Orlistat proves effective and well tolerated in the treatment of obesity

July 1, 1998

Novel aldose reductase inhibitor SG-210 for diabetic complications

July 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...